BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

863 related articles for article (PubMed ID: 10199764)

  • 1. Serum antibodies against the flavoprotein subunit of succinate dehydrogenase are sensitive markers of eye muscle autoimmunity in patients with Graves' hyperthyroidism.
    Gunji K; De Bellis A; Kubota S; Swanson J; Wengrowicz S; Cochran B; Ackrell BA; Salvi M; Bellastella A; Bizzarro A; Sinisi AA; Wall JR
    J Clin Endocrinol Metab; 1999 Apr; 84(4):1255-62. PubMed ID: 10199764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 64-kilodalton eye muscle protein is the flavoprotein subunit of mitochondrial succinate dehydrogenase: the corresponding serum antibodies are good markers of an immune-mediated damage to the eye muscle in patients with Graves' hyperthyroidism.
    Kubota S; Gunji K; Ackrell BA; Cochran B; Stolarski C; Wengrowicz S; Kennerdell JS; Hiromatsu Y; Wall J
    J Clin Endocrinol Metab; 1998 Feb; 83(2):443-7. PubMed ID: 9467555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cloning and characterization of the novel thyroid and eye muscle shared protein G2s: autoantibodies against G2s are closely associated with ophthalmopathy in patients with Graves' hyperthyroidism.
    Gunji K; De Bellis A; Li AW; Yamada M; Kubota S; Ackrell B; Wengrowicz S; Bellastella A; Bizzarro A; Sinisi A; Wall JR
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1641-7. PubMed ID: 10770210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eye muscle antibodies and subtype of thyroid-associated ophthalmopathy.
    Kaspar M; Archibald C; De BA; Li AW; Yamada M; Chang CH; Kahaly G; Wall JR
    Thyroid; 2002 Mar; 12(3):187-91. PubMed ID: 11952037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantibodies to the flavoprotein subunit of succinate dehydrogenase: analysis of specificity in autoimmune thyroid disease.
    Kemp EH; Ridgway JN; Smith KA; Watson PF; Weetman AP
    Clin Endocrinol (Oxf); 2000 Sep; 53(3):291-9. PubMed ID: 10971445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of serum antibodies against three eye muscle antigens and the connective tissue antigen collagen XIII in patients with Graves' disease with and without ophthalmopathy: correlation with clinical features.
    Gopinath B; Musselman R; Adams CL; Tani J; Beard N; Wall JR
    Thyroid; 2006 Oct; 16(10):967-74. PubMed ID: 17042681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyroid-associated ophthalmopathy in black South African patients with Graves' disease: relationship to antiflavoprotein antibodies.
    Joffe B; Gunji K; Panz V; Zouvanis M; Swanson J; Ackrell BA; Wall JR
    Thyroid; 1998 Nov; 8(11):1023-7. PubMed ID: 9848717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies targeting the calcium binding skeletal muscle protein calsequestrin are specific markers of ophthalmopathy and sensitive indicators of ocular myopathy in patients with Graves' disease.
    Gopinath B; Musselman R; Beard N; El-Kaissi S; Tani J; Adams CL; Wall JR
    Clin Exp Immunol; 2006 Jul; 145(1):56-62. PubMed ID: 16792674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eye muscle antibodies in patients with ocular myasthenia gravis: possible mechanism for eye muscle inflammation in acetylcholine-receptor antibody-negative patients.
    Gunji K; Skolnick C; Bednarczuk T; Benes S; Ackrell BA; Cochran B; Kennerdell JS; Wall JR
    Clin Immunol Immunopathol; 1998 Jun; 87(3):276-81. PubMed ID: 9646837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral blood T lymphocyte sensitisation against calsequestrin and flavoprotein in patients with Graves' ophthalmopathy.
    Nguyen B; Gopinath B; Tani J; Wescombe L; Wall JR
    Autoimmunity; 2008 Aug; 41(5):372-6. PubMed ID: 18568642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eye muscle antibodies in Graves' ophthalmopathy: pathogenic or secondary epiphenomenon?
    Mizokami T; Salvi M; Wall JR
    J Endocrinol Invest; 2004 Mar; 27(3):221-9. PubMed ID: 15164997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunologically mediated cytotoxicity against human eye muscle cells in Graves' ophthalmopathy.
    Wang PW; Hiromatsu Y; Laryea E; Wosu L; How J; Wall JR
    J Clin Endocrinol Metab; 1986 Aug; 63(2):316-22. PubMed ID: 3755139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum antibodies reactive with eye muscle antigens and the TSH receptor in a euthyroid subject who developed ophthalmopathy and Graves' hyperthyroidism.
    Wall J; Barsouk A; Stolarski C; Kiljanski J; Stachura I; Nebes V; Peele K; Volpe R; Kennerdell J
    Thyroid; 1996 Aug; 6(4):353-8. PubMed ID: 8875760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reevaluation of the prevalences of serum autoantibodies reactive with "64-kd eye muscle proteins" in patients with thyroid-associated ophthalmopathy.
    Kubota S; Gunji K; Stolarski C; Kennerdell JS; Wall J
    Thyroid; 1998 Feb; 8(2):175-9. PubMed ID: 9510127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies against striated muscle, connective tissue and nuclear antigens in patients with thyroid-associated ophthalmopathy: should Graves' disease be considered a collagen disorder?
    Kiljanski JI; Peele K; Stachura I; Pickeral J; Stolarski C; Kennerdell JS; Wall JR
    J Endocrinol Invest; 1997 Nov; 20(10):585-91. PubMed ID: 9438915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Affinity purification of orbital membrane antigens for the study of the pathogenesis of Graves' ophthalmopathy.
    Salvi M; Bingoye F; Chung F; Wall JR
    J Clin Endocrinol Metab; 1988 May; 66(5):939-45. PubMed ID: 3360902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extraocular muscle antibodies and the occurrence of ophthalmopathy in Graves' disease.
    de Bellis A; Perrino S; Coronella C; Sansone D; Ruocco G; Tirelli G; Di Martino S; Conte M; Bellastella G; Wall JR; Bellastella A; Bizzarro A
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):694-8. PubMed ID: 15163332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody-dependent cell-mediated cytotoxicity against orbital target cells in thyroid-associated ophthalmopathy and related disorders; close relationship between serum cytotoxic antibodies and parameters of eye muscle dysfunction.
    Barsouk A; Peele KA; Kiljanski J; Stolarski C; Nebes V; Kennerdell JS; Volpe R; Wall JR
    J Endocrinol Invest; 1996 Jun; 19(6):334-41. PubMed ID: 8844451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies to porcine eye muscle in patients with Graves' ophthalmopathy: identification of serum immunoglobulins directed against unique determinants by immunoblotting and enzyme-linked immunosorbent assay.
    Ahmann A; Baker JR; Weetman AP; Wartofsky L; Nutman TB; Burman KD
    J Clin Endocrinol Metab; 1987 Mar; 64(3):454-60. PubMed ID: 2434519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of antibodies reactive with a 64 kDa eye muscle membrane antigen in patients with thyroid autoimmunity.
    Miller A; Arthurs B; Boucher A; Liberman A; Bernard N; Rodien P; Salvi M; Wall JR
    Thyroid; 1992; 2(3):197-202. PubMed ID: 1422231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.